|
Market Closed -
Nasdaq
05:00:00 07/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 79.41 USD | -5.98% |
|
-3.50% | +19.65% |
| 10-31 | DexCom Q3 Results, Higher Revenue Guidance Point to Stronger 2027, RBC Says | MT |
| 10-30 | UBS Adjusts DexCom Price Target to $107 From $102, Maintains Buy Rating | MT |
- Stock Market
- Stocks
- DXCM Stock
- Charts DexCom, Inc.
- Static Chart
Select your edition
All financial news and data tailored to specific country editions
